FDA · Drugs · Wednesday, July 15

Bortezomib for Injection 3.5mg/Vial recall

Reliance Life Sciences Private Limited recalled Bortezomib for Injection 3.5mg/Vial on July 15, 2026 because of lack of Sterility Assurance. It was sold nationwide.

Why it was recalled

Lack of Sterility Assurance

What's recalled

Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01

Quantity: 11,400 vials

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice

Details

Company: Reliance Life Sciences Private Limited, Navi Mumbai, N/A
Date: Wednesday, July 15
Severity: Class II
the product could cause temporary or reversible health problems.
Where sold: Nationwide
Nationwide in the USA
Status: Ongoing
Recall number: D-0673-2026
Source: U.S. Food and Drug Administration

More drugs recalls

TRP The Relief Products* Gentle Eyes Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Clear Eyes Redness Relief
Wed, Sep 30 · Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Lubricant Eye Drops-Cameron Pharmaceuticals
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Reliable -1 Laboratories
Wed, Sep 30 · Sterling Pharmaceutical Services LLC